| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |